Institut du Cancer de Montpellier (ICM)

The Institut du Cancer de Montpellier is one of the 18 French Centres de Lutte Contre le Cancer (CLCC) that make up the Unicancer network. It combines a dedicated cancer hospital with the Montpellier Cancer Research Institute (IRCM, Inserm and University of Montpellier) and an early-phase trials unit, and is accredited by the Organisation of European Cancer Institutes as a Comprehensive Cancer Centre. Research strengths include radiotherapy and radiobiology, biomarkers and circulating tumour DNA, colorectal and breast cancer, and supportive care. The institute is part of the Montpellier SIRIC and hosts Unicancer national trials.